Close

 

Fund Holdings (%)1,2 as of Mar 31, 2024

Holding % of Net Assets
Eli Lilly & Co 9.59%
Novo Nordisk A/S 6.96%
UnitedHealth Group Inc 6.81%
AbbVie Inc 5.53%
Thermo Fisher Scientific Inc 4.93%
AstraZeneca PLC 4.54%
Intuitive Surgical Inc 3.92%
Danaher Corp 3.78%
Boston Scientific Corp 3.56%
Roche Holding AG 3.48%
Johnson & Johnson 3.43%
Stryker Corp 3.37%
Sanofi 3.23%
Zoetis Inc 3.12%
Merck & Co Inc 2.59%
Vertex Pharmaceuticals Inc 2.57%
Bristol-Myers Squibb Co 2.41%
CSL Ltd 2.07%
McKesson Corp 2.07%
Alcon Inc 2.02%
Cooper Cos Inc 2.00%
Neurocrine Biosciences Inc 1.78%
SPDR S&P Biotech ETF 1.77%
Lonza Group AG 1.30%
Centene Corp 1.24%
IDEXX Laboratories Inc 1.04%
Pfizer Inc 0.96%
Royalty Pharma PLC 0.93%
Align Technology Inc 0.89%
Mettler-Toledo International Inc 0.88%
Zimmer Biomet Holdings Inc 0.88%
Amplifon SpA 0.86%
Sartorius AG 0.83%
ARGENX SE - ADR 0.83%
Teleflex Inc 0.79%
Straumann Holding AG 0.75%
Neogen Corp 0.64%
AptarGroup Inc 0.62%
Asahi Intecc Co Ltd 0.43%
iShares Global Healthcare ETF 0.25%
JMDC Inc 0.19%
CARIS LIFE SCIENCES, INC 0.05%
DANISH KRONE 0.00%
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO 0.00%